Johnson & Johnson (NYSE:JNJ) Q2 2023 Earnings Call Transcript

Operator: Good morning, and welcome to Johnson & Johnson's Second Quarter 2023 Earnings Conference Call.

Related Keywords

United States ,Russia ,Alameda County ,California ,China ,American ,Johnson ,Erik Haas ,Valadezv Johnson ,Jessica Moore ,Joaquin Duato ,Larry Biegelsen ,Joe Wolk ,Consumer Health ,Consumer Health Business ,Kenvue Inc ,Worldwide Consumer Health ,Bristol Myers Squibb ,Abiomed ,Wells Fargo ,American Urological Association ,York Stock Exchange On ,Amgen ,European Commission ,Cellular Biomedicine Group ,World Congress ,Health Photo ,Interventional Solutions ,Call Transcript July ,Second Quarter ,Vice President ,Investor Relations ,Chief Executive Officer ,Executive Vice President ,Chief Financial Officer ,Worldwide Vice President ,Ablation Catheter ,Novel Oral ,Antagonist Peptide ,Myriam Zilles ,Cellular Biomedicine ,Health For Humanity ,New York Stock Exchange ,Retire Around ,Most Bars ,Judge Kaplan ,Vamil Divan ,